Sean P. Nolan

Companies

• Taysha Gene Therapies, Inc.Chief executive officer Jan 4, 2023 to now¹
• Taysha Gene Therapies, Inc.Board member Sep 23, 2020 to now²
• Ventas, Inc.Board member Jul 26, 2019 to now³
• Social Capital Suvretta Holdings Corp. IIBoard member Sep 24, 2021 to Sep 24, 2021⁴
• Neurogene Inc.Board member Feb 26, 2015 to May 7, 2020⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TGTaysha Gene Therapies, Inc. TSHA4,443,802 shares⁶$17.6M at $3.96Jan 27, 2026
• VVentas, Inc. VTR26,268 shares⁷$2.2M at $84.59May 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 13, 2026Granted 2,047 shares at $90.35 of Ventas, Inc.⁷
• Jan 26, 2026Sold 41,312 shares at $4.61 of Taysha Gene Therapies, Inc.⁶
• Jan 23, 2026Sold 136,789 shares at $4.75 of Taysha Gene Therapies, Inc.⁶
• Jan 12, 2026Granted 1,008,000 shares of Taysha Gene Therapies, Inc.⁸
• May 13, 2025Granted 2,882 shares at $64.18 of Ventas, Inc.⁹
• Jan 2, 2025Granted 892,500 shares of Taysha Gene Therapies, Inc.¹⁰
• May 14, 2024Granted 3,648 shares at $47.96 of Ventas, Inc.¹¹
• Jan 2, 2024Granted 1,184,688 shares of Taysha Gene Therapies, Inc.¹²
• Aug 16, 2023Bought 444,444 shares at $0.90 of Taysha Gene Therapies, Inc.¹³
• May 16, 2023Granted 3,835 shares at $45.63 of Ventas, Inc.¹⁴
• Apr 27, 2022Granted 3,056 shares at $57.25 of Ventas, Inc.¹⁵
• Jul 21, 2020Bought 37 shares at $34.21 of Ventas, Inc.¹⁶
• Jul 21, 2020Bought 27 shares at $34.21 of Ventas, Inc.¹⁶
• Apr 20, 2020Bought 50 shares at $27.70 of Ventas, Inc.¹⁶
• Apr 20, 2020Bought 36 shares at $27.70 of Ventas, Inc.¹⁶